Bayer Shareholders OK Spin Off of Lanxess
551896
Shareholders of German drug maker Bayer AG approved plans Wednesday to spin off chemicals and polymers business Lanxess, clearing the way for its listing on the stock market early next year.
575085
NEW YORK/FRANKFURT  - A drug being developed by  Bayer AG and Onyx Pharmaceuticals Inc. shrank tumors in some  liver cancer patients and temporarily stabilized the disease in  others in a small clinical trial, the companies said on  Wednesday.
177951
HRE's share price jumped 5 per cent as the group, spun out of Munich-based bank HVB last year, said the clean-out of its legacy German business was now complete.
32938
A drug being developed by Bayer AG and Onyx Pharmaceuticals shrank tumors in 9 percent of liver cancer patients in a mid-stage clinical trial, the companies said on Wednesday.
473874
Tyco International Ltd.  said on Thursday it sees no impediments to its plan to spin off two businesses to shareholders later this month, after a group of bondholders said the plan could be delayed because it failed to fulfill obligations to debt holders.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
307295
The influential proxy advisory firm Institutional Shareholder Services reversed its stance yesterday and said that it would recommend that shareholders of Caremark Rx support a takeover proposal from the CVS drugstore chain.
281314
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand ...
480137
The German pharmaceutical giant Bayer is no stranger to health and safety scares. Three years ago, it had to pull its cholesterol-lowering drug Baycol from the market and
314487
German drugmaker Bayer AG on Wednesday announced plans to spin off chemicals and polymers business Lanxess at the beginning of next year, a move designed to help it focus on health care and other core ...
374836
Alcatel  shareholders on  Thursday approved the French telecoms equipment provider's  all-share acquisition of U.S. rival Lucent , putting an  end to weeks of debates about the deal's merits.
419077
LONDON (CBS.MW) -- Bayer AG (DE:575200) (BAY) Monday said it has agreed to sell its plasma products business to NPS BioTherapeutics, Inc.
536231
Investors in Germany's Bayer will get  one share in chemicals and polymers spin-off Lanxess for every  10 Bayer shares held, a German newspaper said, valuing Lanxess  at nearly 1.6 billion euros ($1.97 billion).
567719
Tyco International Ltd.  on Thursday said its board approved the spin-offs of its healthcare and electronics businesses through a tax-free dividend distribution to shareholders.
154457
German drug maker Bayer AG said on Monday  that its drug Nexavar had been approved in Japan for the  treatment of kidney cancer.
103534
Robinson-based Bayer Corp., the US division of Germany&#39;s Bayer AG, yesterday became the first company to settle charges with the US Justice Department for its
750251
BOSTON (CBS.MW) -- Pharmaceutical conglomerates Schering-Plough and Bayer have entered into a broad joint-marketing deal Monday for several of the companies&#39; leading drugs.